Ahmed Nabeel's Form 4 filing
Outset Medical, Inc. (OM) · filed Jan 17, 2024
- Accession no.
- 0001484612-24-000014
- Filed
- Jan 17, 2024
- Trade date
- Jan 12-16, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $7.40K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ahmed NabeelCIK 0001870610 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Common Stock | AGrant or awardAcquired | +136,000 | $0.00 | $0 | 212,819 | Direct | |
| Jan 12, 2024 | Common Stock | AGrant or awardAcquired | +100,000 | $0.00 | $0 | 312,819 | Direct | |
| Jan 12, 2024 | Common Stock | AGrant or awardAcquired | +5,904 | $0.00 | $0 | 318,723 | Direct | |
| Jan 16, 2024 | Common Stock | SSaleDisposed | −1,726 | $4.29 | −$7,404.54 | 316,997 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.